Atlas Trials

Unmodified Versus Leuko-Reduced Allogeneic Red Blood Cells Transfusion in Cancer Patients

Clinical trial NCT00180869 · COMPLETED

Trial details

NCT number
NCT00180869
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
CancerSurgery
Start date
1997-09-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.